Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Risk stratification and early diagnosis of bowel cancer in people with Lynch syndrome

Project description

Colorectal cancer early diagnosis in people with Lynch syndrome

Lynch syndrome (LS) is a hereditary condition that raises the risk of colorectal cancer (CRC), with around 40 % of individuals developing tumours by age 40. Colonoscopies are invasive, costly, and there is a lack of molecular data for improving risk assessment and prevention. The ERC-funded RED-LYNCH project aims to develop a rapid, non-invasive surveillance tool using metabolite biomarkers to meet critical clinical needs. It will assess the reliability of these biomarkers for stratifying CRC risk and diagnosing CRC early in LS carriers. The project will refine high-throughput sample processing methods, gather end-user feedback and explore commercialisation. This tool will provide metabolic profiles to inform personalised nutritional interventions to help reduce CRC risk.

Objective

Lynch syndrome (LS) is a hereditary condition that predisposes carriers to various cancers, particularly colorectal cancer (CRC). Approximately 40% of individuals with LS develop colorectal tumours before the age of 40, with adenomas often exhibiting higher dysplasia and an accelerated progression to carcinoma. Due to this elevated lifetime risk of CRC, clinical guidelines recommend biennial surveillance colonoscopies starting at age 25. However, colonoscopy is invasive, costly, and time-consuming, creating a significant burden for both patients and healthcare systems. Furthermore, it does not provide molecular-level data, which have significant potential to improve CRC risk stratification and inform the development of personalised prevention strategies. To address these unmet clinical needs, this proposal aims to develop a non-invasive and rapid surveillance tool based on circulating metabolite biomarkers. The objectives include evaluating the robustness of these biomarkers in stratifying CRC risk and early diagnosis of CRC among LS carriers, refining analytical methods for high-throughput sample processing, gathering end-user perspectives on the tool, and exploring intellectual property protection and commercialisation pathways. This tool will enable CRC risk stratification and longitudinal monitoring, potentially improving LS carriers’ compliance with routine screening. Additionally, the tool can provide metabolic profiles that may inform personalised nutritional interventions to reduce CRC risk in LS carriers.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-POC

See all projects funded under this call

Host institution

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
Net EU contribution
€ 150 000,00
Address
SOUTH KENSINGTON CAMPUS EXHIBITION ROAD
SW7 2AZ London
United Kingdom
Region
London Inner London — West Westminster
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (1)